Search

everythinglearnresearchcommunity

for

Search:↓

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Blumea eriantha DC extract shows strong potential for promoting hair growth.

Bead-jet printing of stem cells improves muscle and hair regeneration.

The 1927-nm fractionated thulium laser treatment significantly improves hair thickness and count in pattern hair loss patients.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

COVID-19 may increase hair loss, and Nourkrin® could help treat it.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

Finasteride 1 mg significantly improves hair growth in men aged 41 to 60 with male pattern hair loss.

Finasteride 1 mg helps prevent more hair loss in men with male pattern baldness.

Finasteride 1.25 mg showed small improvements in hair density and thickness for female pattern hair loss, but more research is needed.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Using 10% topical minoxidil, oral finasteride, and microneedling together can effectively treat Male Pattern Baldness with high patient satisfaction and no major side effects.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

Low androgen levels can still cause female pattern hair loss.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

A treatment combining laser energy and injections improved hair loss and unexpectedly also reduced hair graying.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.